REVEAL GENOMICS Trademark

Trademark Overview


On Friday, March 19, 2021, a trademark application was filed for REVEAL GENOMICS with the United States Patent and Trademark Office. The USPTO has given the REVEAL GENOMICS trademark a serial number of 79312157. The federal status of this trademark filing is REGISTERED as of Tuesday, February 7, 2023. This trademark is owned by REVEAL GENOMICS S.L.. The REVEAL GENOMICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic biomarker reagents for cancer diagnosis, prognosis and treatment for medical purposes; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagents, namely, clinical medical reagents; diagnostic reagents for medical use; diagnostic biomarker reagents for medical diagnostics

Scientific research for medical purposes in oncology; research and development of biomarkers for cancer diagnosis, prognosis and treatment
reveal genomics

General Information


Serial Number79312157
Word MarkREVEAL GENOMICS
Filing DateFriday, March 19, 2021
Status700 - REGISTERED
Status DateTuesday, February 7, 2023
Registration Number6970213
Registration DateTuesday, February 7, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "REVEAL" in blue and dark blue colors, the letter "A" of which appearing as a double helix design. Below this appears the stylized wording "GENOMICS" in dark blue color.
Goods and ServicesDiagnostic biomarker reagents for cancer diagnosis, prognosis and treatment for medical purposes; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagents, namely, clinical medical reagents; diagnostic reagents for medical use; diagnostic biomarker reagents for medical diagnostics
Indication of Colors claimedThe color(s) blue and dark blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"GENOMICS"
Goods and ServicesScientific research for medical purposes in oncology; research and development of biomarkers for cancer diagnosis, prognosis and treatment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, June 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREVEAL GENOMICS S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES

Party NameREVEAL GENOMICS S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameREVEAL GENOMICS S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 8, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 8, 2023FINAL DISPOSITION PROCESSED
Sunday, May 7, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 7, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, November 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Monday, November 21, 2022NOTIFICATION PROCESSED BY IB
Wednesday, November 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 2, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 2, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 25, 2022EXAMINER'S AMENDMENT ENTERED
Monday, July 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2022EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, June 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 26, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, December 19, 2021REFUSAL PROCESSED BY IB
Thursday, December 2, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 2, 2021REFUSAL PROCESSED BY MPU
Wednesday, November 3, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 2, 2021NON-FINAL ACTION WRITTEN
Sunday, October 24, 2021ASSIGNED TO EXAMINER
Wednesday, June 9, 2021APPLICATION FILING RECEIPT MAILED
Saturday, June 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 3, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB